2-4 We previously reported that

mice transgenic for directed expression of a dominant-negative form of transforming growth factor beta receptor type II (dnTGFβRII), under the control of the CD4 promoter lacking the CD8 silencer, spontaneously develop an autoimmune biliary ductular disease.5 This disease is associated with the spontaneous production of AMAs directed to the same mitochondrial autoantigens recognized by sera from PBC patients6 with lymphocytic liver infiltration and periportal inflammation analogous to human PBC. The murine serum cytokine profile is similar to sera of patients with PBC. These findings indicate that the dnTGFβRII mice are a useful animal model for studying the pathogenic mechanisms of human PBC. We have demonstrated that deleting the p40 chain of interleukin (IL)-12 PD-0332991 ic50 from dnTGFβRII mice produced a marked diminution in the levels of proinflammatory T helper 1 (Th1) cytokines in livers with accompanying reductions in cellular infiltrates in portal tracts and diminished bile duct damage.7 IL-12, the prototypic

member of the heterodimeric family of cytokines, consists of a p40 and a p35 subunit covalently linked by two disulfide linkages. Both p35 and p40 are components of two heterodimeric cytokines in the IL-12 family.8 In order to further examine and differentiate the role of the p35- and p40-containing members of the IL-12 cytokine family in dnTGFβRII disease, we generated an IL-12p35−/− mouse strain on the dnTGFβRII background. Our results indicate 上海皓元 that, in contrast to the IL-12p40−/− mice that were protected from liver inflammation, the IL-12p35−/− mice developed click here liver inflammation with similar severity but delayed onset compared to the parental dnTGFβRII mice. The p35−/− mice demonstrate a distinct cytokine profile, with enhanced IL-17, compared to parental dnTGFβRII and p40−/− mice. Strikingly, deletion of the IL-12p35 subunit from dnTGFβRII mice resulted in frequent development of liver fibrosis. This model is unique in that

it has a resemblance to a number of immunological and histological features of human PBC. Although we do not opine that it recapitulates PBC faithfully, we submit that it is a useful system to dissect the cellular and molecular basis of loss of tolerance and liver damage. AMA, antimitochondrial autoantibodies; dnTGFβRII, dominant-negative form of transforming growth factor beta receptor type II; MNCs, mononuclear cells; PBD, primary biliary cirrhosis; PDC-E2, pyruvate dehydrogenase E2 complex. The dnTGFβRII colony on a B6 background (B6.Cg-Tg(Cd4-TGF BR2)16Flv/J) was maintained at the University of California at Davis animal facility (Davis, CA) and bred as hemizygotes due to the severe inflammatory bowel disease of homozygotes. The dnTGFβRII mice used herein are on a B6 background. Essentially, the transgenic founder mice were backcrossed to B10.